Inhibition of the Raf-MEK1/2-ERK1/2 signaling pathway, Bcl-xL down-regulation, and chemosensitization of non-Hodgkin's lymphoma B cells by Rituximab

Cancer Research (2004) - Comments
pubmed: 15466208 doi: 10.1158/0008-5472.can-03-3500 issn: 0008-5472 issn: 1538-7445

Ali R. Jazirehi, Mario I. Vega, Devasis Chatterjee, Lee Goodglick, Benjamin Bonavida